Not applicableStudy completedNCT06885333
What this trial is testing
Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma
Who this might be right for
GliomaGlioma : Oligodendroglioma or Astrocytoma
West China Hospital 192